J&J investor relations veep Mehrotra retires, Wolk steps up Johnson & Johnson (NYSE:JNJ) said today its 10-year vice president of investor relations Louise Mehrotra will retire, effective January 2017, to be replaced by Joseph Wolk, effective August 1. Wolk previously served as vice president of group finance for Johnson & Johnson’s pharmaceuticals deivision, and has […]
Uroplasty Inc.
BSX pays $63m for Xlumena | The week in medtech M&A
Uroplasty, Vision-Sciences merge as Cogentix
MDT buys hearing aid maker Sophono | The week in medtech M&A
Uroplasty, Vision-Sciences shareholders OK merger
CAH top suitor for JNJ’s Cordis unit | The week in medtech M&A
Cigna to cover Uroplasty’s over-active bladder treatment
Health insurer Cigna has issued a positive coverage decision on Uroplasty’s (NSDQ:UPI) overactive bladder (OAB) treatment, Percutaneous Tibial Nerve Stimulation (PTNS).
Uroplasty, Vision-Sciences set date for merger vote
Uroplasty and Vision-Sciences shareholders will vote on the proposed all-stock merger deal between the two companies on March 30, according to a regulatory filing.
Stryker bid for Smith & Nephew could be in the works | The week in medtech M&A
Echo Therapeutics in midst of a proxy battle with Platinum Management | Medtech personnel moves for the week of Apr. 28, 2014
Orthofix names interim CFO, taps CareFusion CFO for board | Personnel Moves
